APH and ACB crystal ball? CRON is looking Strong
After drawing up the APH and ACB chart I noticed an eerily similar channel which I highlighted in Blue. Could this be the next step for APH and ACB? I am willing to bet on it.
Ok lets look at CRON. CRON was a beast today. It broke 7 once and the rocketed up a solid 14%. On the low of the day to the high CRON Moved over 20%. I expect this run to continue. You want to see it hold 6.30 followed by 6.40 early on. 6.50 and 7.00 are the next resistance and after that there is a lot of room to run. One thing to note the 50% retrace from this dump was at 6.40. If this stock holds that tomorrow then the future is bright. I am long on CRON for the time being but watch out for this a big sticking point. When a stock breaks through here the next resistance is around the 76% mark which is 7.80. Conservative play is to wait for a retest at 6.50 as you have 50 cents there a more aggressive is buy at 6.40 and hope for it to run again. If CRON gets back to the 100 mill deal get out there. It should be its ceiling. This has happened to weed 34.50 and HIP 1.32 more times than I can count.
Ok lets look at CRON. CRON was a beast today. It broke 7 once and the rocketed up a solid 14%. On the low of the day to the high CRON Moved over 20%. I expect this run to continue. You want to see it hold 6.30 followed by 6.40 early on. 6.50 and 7.00 are the next resistance and after that there is a lot of room to run. One thing to note the 50% retrace from this dump was at 6.40. If this stock holds that tomorrow then the future is bright. I am long on CRON for the time being but watch out for this a big sticking point. When a stock breaks through here the next resistance is around the 76% mark which is 7.80. Conservative play is to wait for a retest at 6.50 as you have 50 cents there a more aggressive is buy at 6.40 and hope for it to run again. If CRON gets back to the 100 mill deal get out there. It should be its ceiling. This has happened to weed 34.50 and HIP 1.32 more times than I can count.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.